Investigating the effectiveness of combined T4 and T3 therapy for hypothyroidism
T4/T3 Therapy in Hypothyroidism
This study is looking into how a combination of two thyroid hormones, LT4 and LT3, might help people with hypothyroidism feel better, especially since some still have symptoms even while taking the usual treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11075334 on NIH RePORTER |
What this research studies
This research focuses on hypothyroidism, a condition requiring lifelong thyroid hormone replacement. The standard treatment, Levothyroxine (LT4), does not fully mimic natural thyroid function, which includes both T4 and T3 hormones. Many patients continue to experience symptoms despite LT4 treatment. This study aims to gather data to design a clinical trial that will evaluate the effectiveness of a combination therapy using both LT4 and T3 (LT3) to improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with hypothyroidism who are currently on Levothyroxine but still experience symptoms.
Not a fit: Patients who have not been diagnosed with hypothyroidism or those who are already receiving effective treatment without residual symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment options for patients with hypothyroidism, potentially alleviating persistent symptoms.
How similar studies have performed: Previous research has indicated that combination therapy approaches may improve outcomes for patients with thyroid disorders, suggesting potential success for this study.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Cappola, Anne R — University of Pennsylvania
- Study coordinator: Cappola, Anne R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.